Science-Driven Suppositories

Ebbtide Was Created to Target Menstrual Discomfort at the Source

Ebbtide is Vella Bioscience's first vaginal insert, designed to support comfort and ease with a targeted approach to menstrual and pelvic discomfort. Unlike oral medications that work systemically, this suppository delivers active ingredients, like Vella's proprietary cannabidiol precision technology, locally.

"Menstrual and pelvic discomfort are often minimized or normalized, but they shouldn't be," said Dr. Maria Uloko, MD, board-certified urologist, women's sexual health specialist, and member of Vella's Scientific Advisory Board. "Ebbtide is different because it works at the physiological source of cramping and tension. The underlying science—developed by Vella's R&D team—focuses on reducing uterine contractility through a novel combination of CBD and CBDA." In clinical trials, 81% of women reduced or eliminated their use of oral medications while using Ebbtide.

Localized Biologic Delivery
Targeted vaginal delivery of CBD/CBDA formulations enables higher local bioavailability and reduced systemic exposure, opening pathways for symptom-specific therapeutics.
Cannabinoid Precision Therapeutics
Precision-engineered cannabinoid blends tailored to tissue-specific mechanisms reveal potential for regulated, receptor-specific symptom modulation.
Women-centric Clinical Validation
Robust trial evidence showing reduced oral medication dependence reframes product development priorities toward female-specific pelvic health solutions.

Industries Being Reshaped

Women's Health Devices
Device makers could integrate drug-device combination inserts focused on uterine contractility modulation to create new classes of non-oral therapies.
Pharmaceutical Formulations
Formulation companies specializing in lipophilic cannabinoid stability and mucosal absorption may unlock novel dosage forms with improved onset and durability.
Sexual and Reproductive Wellness Retail
Retailers and DTC brands positioning clinically supported, targeted inserts may shift consumer expectations toward medically validated wellness products.
SCORE
8.0 out of 10
GENDER
10% Men90% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 73%
Activity 76%
Freshness 90%